Adalimumab: A new modality for Behçet's disease? [7]

Additional Metadata
Persistent URL	doi.org/10.1136/ard.2006.064279, hdl.handle.net/1765/35489
Journal	Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Laar, J., Missotten, T., van Daele, P., Jamnitski, A., Baarsma, S.& van Hagen, M. (2007). Adalimumab: A new modality for Behçet's disease? [7]. Annals of the Rheumatic Diseases: An International Peer-reviewed Journal for Health Professionals and Researchers in the Rheumatic Diseases, 66(4), 565–566.https://doi.org/10.1136/ard.2006.064279

Publication